Subarachnoid hemorrhages and aneurysms during the SARS-CoV2-pandemia at a tertiary medical center - Analysis of incidence and outcome.
Corona pandemic
N.I.N.E.
Subarachnoid hemorrhage
Symptomatic aneurysms
Journal
Brain & spine
ISSN: 2772-5294
Titre abrégé: Brain Spine
Pays: Netherlands
ID NLM: 9918470888906676
Informations de publication
Date de publication:
2023
2023
Historique:
received:
12
12
2022
revised:
23
04
2023
accepted:
10
05
2023
medline:
23
5
2023
pubmed:
23
5
2023
entrez:
23
5
2023
Statut:
ppublish
Résumé
During the COVID-19-pandemic a significant decrease of up to 13% of all kinds of medical emergencies was reported. Similar trends were expected for aneurysmal subarachnoid hemorrhages (aSAH) and/or symptomatic aneurysms. To analyze a correlation of the SARS-CoV2-infection and the incidence of aSAH, and to assess the impact of the pandemic-lockdown on the incidence, the outcome and the course of patients suffering from aSAH and/or aneurysms. From March 16th, 2020 (first lockdown in Germany) to January 31st, 2021, all patients admitted to our hospital were screened by polymerase-chain-reaction (PCR) test for genetic material of SARS-CoV2. During this period, aSAH and symptomatic cerebral aneurysms were assessed and retrospectively compared to a historic longitudinal case-cohort. Of 109.927 PCR-tests, 7.856 (7.15%) revealed a SARS-CoV2-infection. None of the patients mentioned above were tested positively. The number of aSAH and symptomatic aneurysms rose by 20.5% (39 vs. 47 cases) (p = 0.93). Poor grade aSAH, as well as extensive bleeding-patterns were more often observed (p = 0.63 and p = 0.40, respectively), with more symptomatic vasospasms diagnosed (5 vs. 9 patients). Mortality rate increased by 8,4%. A correlation between SARS-CoV2-infection and the incidence of aSAH could not be established. Still, the overall number and the number of poor-grade aSAHs increased as well as symptomatic aneurysms during the pandemic. Therefore, we might conclude that dedicated neurovascular competence should be retained in designated centers to care for these patients even or especially in special situations affecting the global healthcare system.
Identifiants
pubmed: 37220490
doi: 10.1016/j.bas.2023.101757
pii: S2772-5294(23)00045-0
pmc: PMC10172152
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101757Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this papesr.
Références
Stroke. 2021 Jan;52(2):716-721
pubmed: 33356382
Stroke. 2019 Jul;50(7):1696-1702
pubmed: 31164068
Stroke. 2009 Jun;40(6):1963-8
pubmed: 19359629
J Am Coll Cardiol. 2020 Sep 15;76(11):1375-1384
pubmed: 32330544
Stroke Vasc Neurol. 2021 Dec;6(4):542-552
pubmed: 33771936
Neurol Res Pract. 2021 Jul 26;3(1):39
pubmed: 34311778
Am J Emerg Med. 2021 Apr;42:203-210
pubmed: 33279331
Rev Neurosci. 2021 Jan 13;32(3):351-361
pubmed: 33618441
Clin Neurol Neurosurg. 2021 Mar;202:106495
pubmed: 33493886
Health Aff (Millwood). 2020 Nov;39(11):2010-2017
pubmed: 32970495
Front Public Health. 2021 Jan 13;8:594117
pubmed: 33520914
Neurol Neurochir Pol. 2022;56(1):96-100
pubmed: 35014691
Clin Neurol Neurosurg. 2022 Sep;220:107370
pubmed: 35882071
Eur Heart J Qual Care Clin Outcomes. 2020 Jul 1;6(3):210-216
pubmed: 32467968
J Neurol Surg A Cent Eur Neurosurg. 2022 Jul 28;:
pubmed: 35901812
J Neurol Neurosurg Psychiatry. 2022 Jul 28;:
pubmed: 35902229
Acta Neurochir (Wien). 2020 Nov;162(11):2715-2724
pubmed: 32974834
Dtsch Arztebl Int. 2008 Apr;105(15):286-91
pubmed: 19629234